423 related articles for article (PubMed ID: 26725200)
21. Characterization of lamin mutation phenotypes in Drosophila and comparison to human laminopathies.
Muñoz-Alarcón A; Pavlovic M; Wismar J; Schmitt B; Eriksson M; Kylsten P; Dushay MS
PLoS One; 2007 Jun; 2(6):e532. PubMed ID: 17565385
[TBL] [Abstract][Full Text] [Related]
22. Patterns of hippocampal tau pathology differentiate neurodegenerative dementias.
Milenkovic I; Petrov T; Kovacs GG
Dement Geriatr Cogn Disord; 2014; 38(5-6):375-88. PubMed ID: 25195847
[TBL] [Abstract][Full Text] [Related]
23. Downregulation of glob1 suppresses pathogenesis of human neuronal tauopathies in Drosophila by regulating tau phosphorylation and ROS generation.
Nisha ; Sarkar S
Neurochem Int; 2021 Jun; 146():105040. PubMed ID: 33865914
[TBL] [Abstract][Full Text] [Related]
24. Dysfunction of lamin A triggers a DNA damage response and cellular senescence.
Lees-Miller SP
DNA Repair (Amst); 2006 Feb; 5(2):286-9. PubMed ID: 16344005
[TBL] [Abstract][Full Text] [Related]
25. Super-Resolution Imaging of the A- and B-Type Lamin Networks: A Comparative Study of Different Fluorescence Labeling Procedures.
Stiekema M; Ramaekers FCS; Kapsokalyvas D; van Zandvoort MAMJ; Veltrop RJA; Broers JLV
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638534
[TBL] [Abstract][Full Text] [Related]
26. Pathogenic tau-induced transposable element-derived dsRNA drives neuroinflammation.
Ochoa E; Ramirez P; Gonzalez E; De Mange J; Ray WJ; Bieniek KF; Frost B
Sci Adv; 2023 Jan; 9(1):eabq5423. PubMed ID: 36608133
[TBL] [Abstract][Full Text] [Related]
27. Molecular genetic analysis of the nested Drosophila melanogaster lamin C gene.
Schulze SR; Curio-Penny B; Li Y; Imani RA; Rydberg L; Geyer PK; Wallrath LL
Genetics; 2005 Sep; 171(1):185-96. PubMed ID: 15965247
[TBL] [Abstract][Full Text] [Related]
28. Oxidative stress mediates tau-induced neurodegeneration in Drosophila.
Dias-Santagata D; Fulga TA; Duttaroy A; Feany MB
J Clin Invest; 2007 Jan; 117(1):236-45. PubMed ID: 17173140
[TBL] [Abstract][Full Text] [Related]
29. The lamin CxxM motif promotes nuclear membrane growth.
Prüfert K; Vogel A; Krohne G
J Cell Sci; 2004 Dec; 117(Pt 25):6105-16. PubMed ID: 15546914
[TBL] [Abstract][Full Text] [Related]
30. An evaluation of Drosophila as a model system for studying tauopathies such as Alzheimer's disease.
Sivanantharajah L; Mudher A; Shepherd D
J Neurosci Methods; 2019 May; 319():77-88. PubMed ID: 30633936
[TBL] [Abstract][Full Text] [Related]
31. Neuron-selective toxicity of tau peptide in a cell culture model of neurodegenerative tauopathy: essential role for aggregation in neurotoxicity.
Zhao K; Ippolito G; Wang L; Price V; Kim MH; Cornwell G; Fulenchek S; Breen GA; Goux WJ; D'Mello SR
J Neurosci Res; 2010 Nov; 88(15):3399-413. PubMed ID: 20882568
[TBL] [Abstract][Full Text] [Related]
32. Biotin rescues mitochondrial dysfunction and neurotoxicity in a tauopathy model.
Lohr KM; Frost B; Scherzer C; Feany MB
Proc Natl Acad Sci U S A; 2020 Dec; 117(52):33608-33618. PubMed ID: 33318181
[TBL] [Abstract][Full Text] [Related]
33. Decreased mechanical stiffness in LMNA-/- cells is caused by defective nucleo-cytoskeletal integrity: implications for the development of laminopathies.
Broers JL; Peeters EA; Kuijpers HJ; Endert J; Bouten CV; Oomens CW; Baaijens FP; Ramaekers FC
Hum Mol Genet; 2004 Nov; 13(21):2567-80. PubMed ID: 15367494
[TBL] [Abstract][Full Text] [Related]
34. Filamin-A and Myosin VI colocalize with fibrillary Tau protein in Alzheimer's disease and FTDP-17 brains.
Feuillette S; Deramecourt V; Laquerriere A; Duyckaerts C; Delisle MB; Maurage CA; Blum D; Buée L; Frébourg T; Campion D; Lecourtois M
Brain Res; 2010 Jul; 1345():182-9. PubMed ID: 20460118
[TBL] [Abstract][Full Text] [Related]
35. The neuropathological spectrum of neurodegenerative tauopathies.
Tolnay M; Probst A
IUBMB Life; 2003 Jun; 55(6):299-305. PubMed ID: 12938731
[TBL] [Abstract][Full Text] [Related]
36. Abnormal bundling and accumulation of F-actin mediates tau-induced neuronal degeneration in vivo.
Fulga TA; Elson-Schwab I; Khurana V; Steinhilb ML; Spires TL; Hyman BT; Feany MB
Nat Cell Biol; 2007 Feb; 9(2):139-48. PubMed ID: 17187063
[TBL] [Abstract][Full Text] [Related]
37. Raphé tauopathy alters serotonin metabolism and breathing activity in terminal Tau.P301L mice: possible implications for tauopathies and Alzheimer's disease.
Menuet C; Borghgraef P; Matarazzo V; Gielis L; Lajard AM; Voituron N; Gestreau C; Dutschmann M; Van Leuven F; Hilaire G
Respir Physiol Neurobiol; 2011 Sep; 178(2):290-303. PubMed ID: 21763469
[TBL] [Abstract][Full Text] [Related]
38. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
39. Laminopathy-causing lamin A mutations reconfigure lamina-associated domains and local spatial chromatin conformation.
Briand N; Collas P
Nucleus; 2018 Jan; 9(1):216-226. PubMed ID: 29517398
[TBL] [Abstract][Full Text] [Related]
40. Partial cleavage of A-type lamins concurs with their total disintegration from the nuclear lamina during apoptosis.
Broers JL; Bronnenberg NM; Kuijpers HJ; Schutte B; Hutchison CJ; Ramaekers FC
Eur J Cell Biol; 2002 Dec; 81(12):677-91. PubMed ID: 12553668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
